Open Calls for Input and Feedback


Listed are current opportunities for patient groups, clinician groups, drug plans, and cancer agencies to provide input or feedback on drugs being assessed within the reimbursement review process.

At CADTH, input is information, insight, or advice given to CADTH to contribute to a review. Feedback is a response to a prepared proposal, review report, or draft recommendation.

Draft Recommendations

faricimab (Vabysmo)

Therapeutic Area: Diabetic Macular Edema
Draft recommendations posted for stakeholder feedback: September 15, 2022
End of feedback period: September 29, 2022
Draft Recommendation

Submit Feedback

 

empagliflozin (Jardiance)

Therapeutic Area: Heart failure
Draft recommendations posted for stakeholder feedback: September 15, 2022
End of feedback period: September 29, 2022
Draft Recommendation

Submit Feedback

 

 

Open Calls for Patient and Clinician Input

Therapeutic Area
Therapeutic Area: Human immunodeficiency virus type 1 (HIV-1)
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Crohn's disease
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Amyotrophic lateral sclerosis (ALS)
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: AChR antibody-positive generalized Myasthenia Gravis
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Neurofibromatosis type 1
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Anemia due to chronic kidney disease
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Fibrodysplasia Ossificans Progressiva
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: ankylosing spondylitis
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Heart failure
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Psoriasis, moderate to severe plaque
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed: